News

The Impact Journals news page hosts content about important news articles and press releases from our Journals and Editorial Board Members.

News

Mission
The Impact Journals news page hosts articles about important news stories from our journals and within the scientific community. Visit this page for the latest in medical advances, pharmaceutical progress, conference reports, and more.

ATR Inhibition Using Gartisertib in Patient-derived Glioblastoma Cell Lines

News

January 17, 2024
PRESS RELEASE: On January 16, 2024, a new research paper was published in Oncotarget, entitled, “ATR inhibition using gartisertib enhances cell death and synergises with temozolomide and radiation in patient-derived glioblastoma cell lines.” continue reading »

Aberrant RBMX Expression Relevant for Cancer Prognosis and Immunotherapy Response

Aging

January 17, 2024
PRESS RELEASE: A new research paper was published in Aging's Volume 16, Issue 1, entitled, “Aberrant RBMX expression is relevant for cancer prognosis and immunotherapy response.” continue reading »

Reductive Carboxylation of Glutamine as a Potential Target in AML

News

January 16, 2024
PRESS RELEASE: On December 1, 2023, a new editorial was published in Oncotarget, entitled, “Reductive carboxylation of glutamine as a potential target in acute myeloid leukemia.” continue reading »

Effects of Resveratrol on Circadian Clock Gene Expression in Young and Older Human Cells

Aging

January 15, 2024
PRESS RELEASE: A new research paper was published on the cover of Aging's Volume 16, Issue 1, entitled, “Effects of resveratrol on in vitro circadian clock gene expression in young and older human adipose-derived progenitor cells.” continue reading »

Pazopanib in EWSR1-NFATC2 Translocation-associated Bone Sarcoma

News

January 12, 2024
PRESS RELEASE: On September 20, 2023, a new case report was published in Oncoscience, entitled, “Activity of pazopanib in EWSR1-NFATC2 translocation-associated bone sarcoma.” continue reading »